• ORPHENADRINE CITRATE CHEMBL1200395 FDA Approved

    Alternate Names:

    Orphenadrine (citrate)
    Orphenadrine Citrate
    Orphenadine Citrate
    Norflex
    N,N-DIMETHYL-2-[(2-METHYLPHENYL)-PHENYL-METHOXY]ETHANAMINE; 2-OXIDANYLPROPANE-1,2,3-TRICARBOXYLIC ACID
    N,N-DIMETHYL-2-[(2-METHYLPHENYL)(PHENYL)METHOXY]ETHANAMINE 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE
    N,N-DIMETHYL-2-(PHENYL(O-TOLYL)METHOXY)ETHANAMINE 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE
    (+-)-N,N-DIMETHYL-2-((O-METHYL-ALPHA-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1)
    N,N-DIMETHYL-2-((O-METHYL-ALPHA-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1)
    (+-)-N,N-DIMETHYL-2-((O-METHYL-ALPHA-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE
    N,N-DIMETHYL-2-((O-METHYL-ALPHA-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE
    CITRIC ACID; N,N-DIMETHYL-2-[O-TOLYL(PHENYL)METHOXY]ETHANAMINE
    3B3-055159
    T6647365
    I06-1758
    A826945
    D00774
    EN300-53019
    ST51053224
    FT-0673305
    LS-175025
    AB2000458
    SMR000058817
    SAM002589900
    SAM002554918
    OR272303
    OR026096
    AK117797
    NCGC00254980-01
    NCGC00094745-03
    NCGC00094745-02
    NCGC00015771-13
    NSC-757238
    NE62567
    NC00525
    MCULE-5864907407
    CS-2426
    TOX21_111323_1
    AKOS008132385
    NSC757238
    CCG-40242
    AN-903
    TOX21_301079
    TOX21_113543
    TOX21_111323
    AC1L3690
    PHARMAKON1600-01500447
    HMS3370M12
    HMS3259M21
    HMS2231J06
    HMS2091L10
    HMS1920D10
    MOLPORT-003-666-248
    HY-B0369A
    HMS502K15
    CTK7J1567
    CITRIC ACID; ORPHENADRINE
    C24H31NO8
    C18H23NO.C6H8O7
    SPECTRUM1500447
    SCHEMBL119470
    MLS000069549
    ORPHENADRINE CITRATE [USAN]
    ORPHENADRINE CITRATE (USP)
    AC1Q74TZ
    NORFLEX (TN)
    CITRO; ORPHENADRINE
    ORPHENADRINECITRATE
    CAS-4682-36-4
    N,N-DIMETHYL-2-[(2-METHYLPHENYL)-PHENYLMETHOXY]ETHANAMINE; 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID
    CPD000058817
    ETHYLAMINE, N,N-DIMETHYL-2-((O-METHYL-ALPHA-PHENYLBENZYL)OXY)-, CITRATE (1:1)
    DSSTOX_GSID_44678
    DSSTOX_RID_80390
    DSSTOX_CID_24678
    NCGC00094745-01
    2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID; DIMETHYL({2-[(2-METHYLPHENYL)(PHENYL)METHOXY]ETHYL})AMINE
    EINECS 225-137-5
    4596-23-0
    CHEBI:7790
    NORFLEX (PHARMACEUTICAL)
    TEGA-FLEX
    EUFLEX
    PLENACTOL
    ORPHENADRINE DIHYDROGEN CITRATE
    X-OTAG
    4682-36-4
    FLEXON
    83823
    FLEXOR

    Drug Info:

    (0 More Sources)

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Histamine H1 receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Glutamate [NMDA] receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Glutamate [NMDA] receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Glutamate [NMDA] receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Glutamate [NMDA] receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Glutamate [NMDA] receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Glutamate [NMDA] receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Mechanism of Interaction Norepinephrine transporter inhibitor
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Glutamate [NMDA] receptor antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications:

  • Interaction Types:
    blocker

    Interaction Info:
    Mechanism of Interaction Sodium channel alpha subunit blocker
    Direct Interaction yes

    Publications: